We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July 2021. In future, IDS and EUROIMMUN will closely cooperate in the fields of research and development, production as well as distribution. IDS is a leading company […]
Always the perfect match for the automation of your lab routine EUROIMMUN has been building expertise in immunofluorescence diagnostics since the 1980s. The indirect immunofluorescence assay (IFA) serves as an essential screening method for detecting many types of autoantibodies. It offers a broad antigen spectrum due to the use of cells and tissues as antigenic
Since end of 2020, different SARS-CoV-2 variants have appeared worldwide − alpha (B.1.1.7), beta (B.1.351), gamma (P.1/B.1.1.128) and delta (B1.617.2) − which are in part more contagious than the original virus type and are therefore spreading more quickly within populations. These variants reveal genetic changes (mutations) in the so-called receptor binding domain (RBD), which is
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 8th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany “The Times They Are a-Changin” is one of the best known songs from Bob Dylan, a winner of the Nobel Prize for Literature. As frequently acknowledged, the
Six months after the start of the COVID-19 vaccination campaign in Germany, half of the population has received at least one vaccination dose. According to the Federal Ministry of Health, 37.9% of them have already been fully vaccinated (as of 02.07.2021). Currently there are four different COVID-19 vaccines available in Germany, which differ slightly in
